{
    "clinical_study": {
        "@rank": "114200", 
        "arm_group": {
            "arm_group_label": "Infection Prone Patients Prior to CIED", 
            "arm_group_type": "Experimental", 
            "description": "Administration of high-dose antibiotics (CIA-RNPT)"
        }, 
        "brief_summary": {
            "textblock": "Following previous positive experience with CITA-RNPT of infected pacemakers, we suggest\n      that CITA-RNPT can be administered prophylactically to patients prior to replacement of\n      CIED, immun-compromised patients, and others."
        }, 
        "brief_title": "Prophylactic Treatment of High-Risk Patients With Cardiovascular Implantable Electronic Devices (CIED)With Continuous In-Situ Ultra High-Dose Antibiotics (CITA) Under Regulated Negative Pressure-Assisted Wound Therapy (RNPT)", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Infection", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  High-risk patients for CIED infections\n\n        Exclusion Criteria:\n\n          -  All others"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01770067", 
            "org_study_id": "0093-12-HYMC"
        }, 
        "intervention": {
            "arm_group_label": "Infection Prone Patients Prior to CIED", 
            "intervention_name": "CITA-RNPT", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Anti-Bacterial Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Cardiac Resynchronization Therapy Devices", 
        "lastchanged_date": "January 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hadera", 
                    "country": "Israel", 
                    "zip": "38100"
                }, 
                "name": "Hillel Yaffe Medical Center"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "topazmd@netvision.net.il", 
            "last_name": "Moris Topaz, MD, PhD", 
            "phone": "972-4-630-4689"
        }, 
        "overall_official": {
            "affiliation": "Hillel Yaffe Medical Center", 
            "last_name": "Moris Topaz, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Lack of CIED Infection", 
            "safety_issue": "No", 
            "time_frame": "Six months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01770067"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Hillel Yaffe Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hillel Yaffe Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}